Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
about
Direct, activating interaction between glycogen synthase kinase-3beta and p53 after DNA damageTherapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorderThe role of lithium in the treatment of bipolar disorder: convergent evidence for neurotrophic effects as a unifying hypothesisLithium facilitates apoptotic signaling induced by activation of the Fas death domain-containing receptorA new look at an old drug: neuroprotective effects and therapeutic potentials of lithium saltsBeyond Monoamines-Novel Targets for Treatment-Resistant Depression: A Comprehensive ReviewMood stabilizers, glycogen synthase kinase-3beta and cell survivalSynergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibitionActivation of Wnt signaling rescues neurodegeneration and behavioral impairments induced by beta-amyloid fibrilsLithium inhibits aluminum-induced apoptosis in rabbit hippocampus, by preventing cytochrome c translocation, Bcl-2 decrease, Bax elevation and caspase-3 activation.Stress-induced structural remodeling in hippocampus: prevention by lithium treatment.Proteomic analysis of lithium-induced gene expression in the rat hypothalamus.A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic?Beneficial effects of mood stabilizers lithium, valproate and lamotrigine in experimental stroke models.The neurotrophic and neuroprotective effects of psychotropic agents.Lithium ameliorates autistic-like behaviors induced by neonatal isolation in rats.Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity.Posterior cerebellar vermal deficits in bipolar disorder.Postural control in bipolar disorder: increased sway area and decreased dynamical complexity.Phosphorylation of tau protein over time in rats subjected to transient brain ischemia.Neuroplasticity and cellular resilience in mood disorders.Dose-dependent protective effect of lithium chloride on retinal ganglion cells is interrelated with an upregulated intraretinal BDNF after optic nerve transection in adult rats.Emerging trends in the treatment of rapid cycling bipolar disorder: a selected review.The mood-stabilizer lithium prevents hippocampal apoptosis and improves spatial memory in experimental meningitis.PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers.Neuronal pentraxin 1 induction in hypoxic-ischemic neuronal death is regulated via a glycogen synthase kinase-3α/β dependent mechanismNeuroprotective effects of lithium in cultured cells and animal models of diseases.Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.The Wnt signaling pathway in bipolar disorder.NMDA receptor antagonists augment antidepressant-like effects of lithium in the mouse forced swimming test.Postinsult treatment with lithium reduces brain damage and facilitates neurological recovery in a rat ischemia/reperfusion model.The paradoxical pro- and anti-apoptotic actions of GSK3 in the intrinsic and extrinsic apoptosis signaling pathways.GSK-3 as a Target for Lithium-Induced Neuroprotection Against Excitotoxicity in Neuronal Cultures and Animal Models of Ischemic Stroke.Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disordersNeuroprotective action of lithium in disorders of the central nervous system.Enhancing synaptic plasticity and cellular resilience to develop novel, improved treatments for mood disorders.Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins.Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons.Lithium ameliorates neurodegeneration, suppresses neuroinflammation, and improves behavioral performance in a mouse model of traumatic brain injury.
P2860
Q24534352-EAA4BFB8-C419-4B80-804F-0D9F543D321FQ24626017-4EF520D4-6C40-4459-8864-2F522D329848Q24651407-A7D98856-8278-48B1-B048-57B9EAAAC7A2Q24791054-F0B79FC9-EA5D-493A-B22E-2F80265BBF21Q26741164-0BC2FC47-7AAA-4930-B5D1-F03415BAF468Q26782993-36A9A920-0BBA-474E-9887-299C89A2476EQ28216404-BDE67C7B-3EEB-4BEE-AB0B-966C9A45E0C4Q28468536-0483BC40-FD93-4D4B-A7B0-72721FC219A1Q28570115-A5AFD971-1716-4350-932F-290A5907E0C3Q30309593-95C42BB3-D350-441E-A87B-F87F1A45DE40Q30542879-12FF05A1-5A0F-4E48-8605-4A0E2A1C5A8DQ30891339-F18A147D-84C9-488C-ACDF-FA4572BFDAF1Q33284843-96447054-1B8F-41F0-AB37-0D27F3AB57B2Q33566724-BAA04A04-9B59-4E6E-AEA5-C9026837455EQ33583992-C74EDB7F-467E-406C-AEF3-A7550196D861Q33810377-A7EF2D0C-EE6C-4622-99DF-085543F73A08Q33844558-B6CE2B37-A897-4435-83AA-DB1468EAF09CQ33904292-4C14187D-5412-4293-B9A5-BF6AC8CBF014Q33911062-B1F9264F-9D90-4CE5-A057-C83FB12C23F0Q34095784-B1BD1DCB-D8CD-4449-88F4-DC813718E98EQ34111006-AC4BF576-B297-42C2-BA8D-AB645741926FQ34158396-C0E8B0E9-3546-42EC-B652-17D37AB68587Q34185305-FD38A4CB-FF38-498A-9E4F-BA81E2B05347Q34542607-36025E67-BDC6-4F88-929A-250218362F42Q34622380-1E25A655-BEAF-41C2-A68A-FF60A2BA605FQ34665731-D28A3C3D-7F3D-4DC4-9B27-3F202DC90EFDQ34692758-B1DFC558-2F66-4DBC-AAF7-B5374F9A0E14Q34692767-71714248-D045-48C3-8E74-5F59B0839185Q34766451-A5919B38-615F-475C-ABE0-3E9384D4B14BQ34956351-12007424-A5C2-4E79-B46B-181165A4D2C6Q34974649-62ACD58E-0424-42F0-BB58-272A239B9142Q35023242-052AAEFF-6110-4046-AB4C-C075217D6390Q35103813-25EF58E1-972C-4F47-85A9-34851C0A8B04Q35154467-E6A45F79-B596-47DC-A13A-FC104D4ADB63Q35197096-74DC7BC7-6131-46B9-A095-A4C4BC48A5CAQ35212429-387652A6-DEFA-4F4E-9847-10560F7DFBF8Q35236446-C5025BB7-30DF-4A2C-8900-D8A710A24690Q35252378-527C3494-B399-4305-8235-9B9468FDD4EAQ35563894-B98044E4-1090-41EF-B289-014D2B215684Q35682342-EE4ABF6D-C8A8-4AA9-B1E8-FC1EE42A891D
P2860
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@ast
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@en
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@nl
type
label
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@ast
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@en
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@nl
prefLabel
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@ast
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@en
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@nl
P1433
P1476
Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats.
@en
P2093
P304
P356
10.1097/00001756-199806220-00031
P577
1998-06-01T00:00:00Z